adcetris
takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - Æxlishemjandi lyf - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.
portrazza
eli lilly nederland b.v. - necitumumab - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - portrazza ásamt gemcitabin og cisplatíni lyfjameðferð er ætlað fyrir meðferð fullorðinn sjúklinga með staðnum háþróaður eða sjúklingum api vöxt þáttur viðtaka (egfr) tjá æxli ekki lítið klefi lungnakrabbamein sem hafa ekki fengið áður en lyfjameðferð í þessu ástandi.
norditropin flexpro stungulyf, lausn 5/1,5 mg/ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 5/1,5 mg/ml
norditropin flexpro stungulyf, lausn 15/1,5 mg/ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 15/1,5 mg/ml
norditropin flexpro stungulyf, lausn 10/1,5 mg/ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 10/1,5 mg/ml
norditropin nordiflex stungulyf, lausn í áfylltum lyfjapenna 5 mg /1,5 ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn í áfylltum lyfjapenna - 5 mg /1,5 ml
norditropin nordiflex stungulyf, lausn í áfylltum lyfjapenna 15 mg/1,5 ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn í áfylltum lyfjapenna - 15 mg/1,5 ml
genotropin stungulyfsstofn og leysir, lausn 12 mg
pfizer aps - somatropinum inn - stungulyfsstofn og leysir, lausn - 12 mg
genotropin stungulyfsstofn og leysir, lausn 5 mg
pfizer aps - somatropinum inn - stungulyfsstofn og leysir, lausn - 5 mg
norditropin nordiflex stungulyf, lausn í áfylltum lyfjapenna 10 mg/1,5 ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn í áfylltum lyfjapenna - 10 mg/1,5 ml